Exact Mass: 490.3195

Exact Mass Matches: 490.3195

Found 123 metabolites which its exact mass value is equals to given mass value 490.3195, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Arachidonoyl Tryptophan

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]-3-(1H-indol-3-yl)propanoate

C31H42N2O3 (490.3195)


N-arachidonoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Sapacitabine

N-{1-[3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide

C26H42N4O5 (490.3155)


   
   

CHEMBL3138508

CHEMBL3138508

C29H46O6 (490.3294)


   

Stereonsteroid F

Stereonsteroid F

C29H46O6 (490.3294)


   

Asparacosin B

Asparacosin B

C29H46O6 (490.3294)


   
   

(17R,20R)-7beta,20,23,29-tetrahydroxy-28-norlupane-3,16-dione

(17R,20R)-7beta,20,23,29-tetrahydroxy-28-norlupane-3,16-dione

C29H46O6 (490.3294)


   

(3beta,5beta,22R)-22-Ac-3,14,22,25-Tetrahydroxycholest-7-en-6-one

(3beta,5beta,22R)-22-Ac-3,14,22,25-Tetrahydroxycholest-7-en-6-one

C29H46O6 (490.3294)


   

2-deoxy-alpha-ecdysone 3-acetate

2-deoxy-alpha-ecdysone 3-acetate

C29H46O6 (490.3294)


   

3beta-malonyloxy-15-(3-methylvaleryloxy)-ent-labda-7,13E-diene|3beta-malonyloxy-15-<3-methylvaleryloxy>-ent-labda-7,13E-diene

3beta-malonyloxy-15-(3-methylvaleryloxy)-ent-labda-7,13E-diene|3beta-malonyloxy-15-<3-methylvaleryloxy>-ent-labda-7,13E-diene

C29H46O6 (490.3294)


   

(1beta,3beta,11alpha,22alpha)-22,26-dimethoxyfurosta-5,25(27)-diene-1,3,11-triol

(1beta,3beta,11alpha,22alpha)-22,26-dimethoxyfurosta-5,25(27)-diene-1,3,11-triol

C29H46O6 (490.3294)


   
   

(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol

(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol

C25H46O9 (490.3142)


   

Methyl diacetylchenodesoxycholate

Methyl diacetylchenodesoxycholate

C29H46O6 (490.3294)


   

Methyl 3,12-diacetoxycholanate

Methyl 3,12-diacetoxycholanate

C29H46O6 (490.3294)


   

9alpha,11alpha-epoxy cholest-7-en-beta,5alpha,6beta,19-tetraol-6-acetate|9alpha,11alpha-epoxycholest-7-en-3beta,5alpha,6beta,19-tetraol 6-acetate|9alpha,11alpha-Epoxycholest-7-ene-3beta,5alpha,6beta,19-tetrol 6-acetate

9alpha,11alpha-epoxy cholest-7-en-beta,5alpha,6beta,19-tetraol-6-acetate|9alpha,11alpha-epoxycholest-7-en-3beta,5alpha,6beta,19-tetraol 6-acetate|9alpha,11alpha-Epoxycholest-7-ene-3beta,5alpha,6beta,19-tetrol 6-acetate

C29H46O6 (490.3294)


   

(17R)-19(18?17)-abeo-2alpha,16beta,18beta,23,24-pentahydroxy-28-norolean-12-en-3-one|stewertiisin B

(17R)-19(18?17)-abeo-2alpha,16beta,18beta,23,24-pentahydroxy-28-norolean-12-en-3-one|stewertiisin B

C29H46O6 (490.3294)


   

3beta,4beta,23,30-tetrahydroxy-24-norolean-12-ene-28-oic acid

3beta,4beta,23,30-tetrahydroxy-24-norolean-12-ene-28-oic acid

C29H46O6 (490.3294)


   

ximasteroid D

ximasteroid D

C29H46O6 (490.3294)


   

26-nor-11,23-dioxo-5alpha-lanost-8-en-3beta,7beta,15alpha,25-tetrol

26-nor-11,23-dioxo-5alpha-lanost-8-en-3beta,7beta,15alpha,25-tetrol

C29H46O6 (490.3294)


   

(3beta,5alpha,6alpha,9alpha,11beta)-cholest-7-ene-11,19-oxido-3,5,6,9-tetrol 6-acetate|dysideasterol F

(3beta,5alpha,6alpha,9alpha,11beta)-cholest-7-ene-11,19-oxido-3,5,6,9-tetrol 6-acetate|dysideasterol F

C29H46O6 (490.3294)


   

3-Ac-3,5,6-Trihydroxy-9-oxo-9,11-secocholest-en-11-al

3-Ac-3,5,6-Trihydroxy-9-oxo-9,11-secocholest-en-11-al

C29H46O6 (490.3294)


   

16-acetoxy-dihydrodeoxoscalarin

16-acetoxy-dihydrodeoxoscalarin

C29H46O6 (490.3294)


   

Ajugasteron B

Ajugasteron B

C29H46O6 (490.3294)


   

13,14-Dihydro,6-(2-methylpropanoyl),7-angeloyl-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

13,14-Dihydro,6-(2-methylpropanoyl),7-angeloyl-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

C29H46O6 (490.3294)


   

(1beta,2alpha,3beta,5alpha,20S)-1,3,20-trihydroxy-4,4,14-trimethyl-15-oxopregn-8-en-2-yl 3-methylbutanoate|xylariacin A

(1beta,2alpha,3beta,5alpha,20S)-1,3,20-trihydroxy-4,4,14-trimethyl-15-oxopregn-8-en-2-yl 3-methylbutanoate|xylariacin A

C29H46O6 (490.3294)


   

Isothankunic acid

Isothankunic acid

C29H46O6 (490.3294)


   

Phe Ile Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Phe Ile Leu Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Phe Ile Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Ile Val Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Leu Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Phe Leu Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Phe Leu Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Leu Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Val Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Val Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Val Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Phe Val Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Ile Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Ile Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Ile Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Ile Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Ile Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Ile Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Ile Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Ile Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Ile Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Ile Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Ile Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Ile Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Leu Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Leu Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Leu Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Leu Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Leu Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Leu Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Leu Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H42N4O5 (490.3155)


   

Leu Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Leu Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Leu Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Leu Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Leu Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Val Phe Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Phe Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Phe Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Phe Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Ile Phe Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Ile Phe Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Ile Ile Phe

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Val Ile Leu Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Val Leu Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Leu Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C26H42N4O5 (490.3155)


   

Val Leu Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

Val Leu Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C26H42N4O5 (490.3155)


   

3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid

3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid

C25H46O9 (490.3142)


   

ST 29:3;O6

9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol

C29H46O6 (490.3294)


   

Chenodeoxycholic acid diacetate methyl ester

Chenodeoxycholic acid diacetate methyl ester

C29H46O6 (490.3294)


   

Sapacitabine

Sapacitabine

C26H42N4O5 (490.3155)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000970 - Antineoplastic Agents Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.

   

3α,12α-Diacetoxy-5β-cholan-24-oic acid methyl ester

3α,12α-Diacetoxy-5β-cholan-24-oic acid methyl ester

C29H46O6 (490.3294)


   

Edasalonexent

Edasalonexent

C31H42N2O3 (490.3195)


C78281 - Agent Affecting Musculoskeletal System

   

N-Arachidonoyl Tryptophan

N-Arachidonoyl Tryptophan

C31H42N2O3 (490.3195)


   

Mgdg O-13:1_3:0

Mgdg O-13:1_3:0

C25H46O9 (490.3142)


   

Mgdg O-14:1_2:0

Mgdg O-14:1_2:0

C25H46O9 (490.3142)


   

[(4E,8E)-2-(butanoylamino)-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(butanoylamino)-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

[(4E,8E)-2-acetamido-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-acetamido-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

[(4E,8E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

[(4E,8E)-2-(hexanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(hexanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

[(4E,8E)-2-(heptanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(heptanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H47N2O6P (490.3172)


   

9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol

9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol

C29H46O6 (490.3294)


   

NA-Trp 20:4(5Z,8Z,11Z,14Z)

NA-Trp 20:4(5Z,8Z,11Z,14Z)

C31H42N2O3 (490.3195)


   
   

ST 23:2;O;Hex

ST 23:2;O;Hex

C29H46O6 (490.3294)


   
   

5,7-dihydroxy-2-(hydroxymethyl)-15-methyl-14-(6-methylheptan-2-yl)-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-9-en-8-yl acetate

5,7-dihydroxy-2-(hydroxymethyl)-15-methyl-14-(6-methylheptan-2-yl)-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-9-en-8-yl acetate

C29H46O6 (490.3294)


   

3-[(1,1,4a,6-tetramethyl-5-{3-methyl-5-[(3-methylpentanoyl)oxy]pent-3-en-1-yl}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl)oxy]-3-oxopropanoic acid

3-[(1,1,4a,6-tetramethyl-5-{3-methyl-5-[(3-methylpentanoyl)oxy]pent-3-en-1-yl}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl)oxy]-3-oxopropanoic acid

C29H46O6 (490.3294)


   

3,4,7-trihydroxy-1-(6-hydroxy-4-oxoheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

3,4,7-trihydroxy-1-(6-hydroxy-4-oxoheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

C29H46O6 (490.3294)


   

26-nor-11,23-dioxo-5α-lanost-8-en-3β,7β,l5α,25-tetrol

NA

C29H46O6 (490.3294)


{"Ingredient_id": "HBIN004959","Ingredient_name": "26-nor-11,23-dioxo-5\u03b1-lanost-8-en-3\u03b2,7\u03b2,l5\u03b1,25-tetrol","Alias": "NA","Ingredient_formula": "C29H46O6","Ingredient_Smile": "CC(CC(=O)CC(C)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

asparacosin b

NA

C29H46O6 (490.3294)


{"Ingredient_id": "HBIN017093","Ingredient_name": "asparacosin b","Alias": "NA","Ingredient_formula": "C29H46O6","Ingredient_Smile": "CC1CCC2(C(C3(C(O2)CC4C3(C(=O)CC5C4CCC6C5(CCC(C6)(OC)OC)C)C)O)C)OC1","Ingredient_weight": "490.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1865","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21575013","DrugBank_id": "NA"}

   

(2s,3r)-2-[(1r,3as,5as,7s,9ar,9br,11ar)-3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylheptan-3-yl acetate

(2s,3r)-2-[(1r,3as,5as,7s,9ar,9br,11ar)-3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylheptan-3-yl acetate

C29H46O6 (490.3294)


   

1,8,9-trihydroxy-7,7-bis(hydroxymethyl)-3',3',4a,4b,10a-pentamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-4'-one

1,8,9-trihydroxy-7,7-bis(hydroxymethyl)-3',3',4a,4b,10a-pentamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-4'-one

C29H46O6 (490.3294)


   

(1r,6r,7r,9r,10r,12r,15r,16r,18s,20r,21r)-11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

(1r,6r,7r,9r,10r,12r,15r,16r,18s,20r,21r)-11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

C29H46O6 (490.3294)


   

(2s)-2-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl (9z)-hexadec-9-enoate

(2s)-2-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl (9z)-hexadec-9-enoate

C25H46O9 (490.3142)


   

(1'r,2r,2's,4's,5r,7's,8's,9's,12's,13's,18'r)-8'-hydroxy-16',16'-dimethoxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

(1'r,2r,2's,4's,5r,7's,8's,9's,12's,13's,18'r)-8'-hydroxy-16',16'-dimethoxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C29H46O6 (490.3294)


   

11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

C29H46O6 (490.3294)


   

(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-1-[(2r)-6-hydroxy-4-oxoheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-1-[(2r)-6-hydroxy-4-oxoheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one

C29H46O6 (490.3294)


   

(1r,3as,4s,5as,5br,7as,11as,11br,13s,13as,13bs)-13-(acetyloxy)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-hexadecahydrochryseno[1,2-c]furan-4-yl acetate

(1r,3as,4s,5as,5br,7as,11as,11br,13s,13as,13bs)-13-(acetyloxy)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-hexadecahydrochryseno[1,2-c]furan-4-yl acetate

C29H46O6 (490.3294)


   

(1'r,2s,2's,4s,4's,5r,7's,8'r,9's,12's,13's,16's,18'r)-4,5,16'-trihydroxy-4-isopropyl-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-20'-one

(1'r,2s,2's,4s,4's,5r,7's,8'r,9's,12's,13's,16's,18'r)-4,5,16'-trihydroxy-4-isopropyl-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-20'-one

C29H46O6 (490.3294)


   

(1r,3ar,5ar,5br,6s,7ar,8r,11ar,11br,13ar,13bs)-1-[(2r)-1,2-dihydroxypropan-2-yl]-6-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-tetradecahydro-1h-cyclopenta[a]chrysene-4,9-dione

(1r,3ar,5ar,5br,6s,7ar,8r,11ar,11br,13ar,13bs)-1-[(2r)-1,2-dihydroxypropan-2-yl]-6-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-tetradecahydro-1h-cyclopenta[a]chrysene-4,9-dione

C29H46O6 (490.3294)


   

(1s,3ar,5as,7r,8s,9s,9as,11ar)-7,9-dihydroxy-1-[(1s)-1-hydroxyethyl]-3a,6,6,9a,11a-pentamethyl-3-oxo-1h,2h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl 3-methylbutanoate

(1s,3ar,5as,7r,8s,9s,9as,11ar)-7,9-dihydroxy-1-[(1s)-1-hydroxyethyl]-3a,6,6,9a,11a-pentamethyl-3-oxo-1h,2h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl 3-methylbutanoate

C29H46O6 (490.3294)


   

2-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl hexadec-9-enoate

2-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl hexadec-9-enoate

C25H46O9 (490.3142)


   

7,9-dihydroxy-1-(1-hydroxyethyl)-3a,6,6,9a,11a-pentamethyl-3-oxo-1h,2h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl 3-methylbutanoate

7,9-dihydroxy-1-(1-hydroxyethyl)-3a,6,6,9a,11a-pentamethyl-3-oxo-1h,2h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl 3-methylbutanoate

C29H46O6 (490.3294)


   

8'-hydroxy-16',16'-dimethoxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

8'-hydroxy-16',16'-dimethoxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one

C29H46O6 (490.3294)


   

3-{[(2s,4as,5r,8as)-1,1,4a,6-tetramethyl-5-[(3e)-3-methyl-5-{[(3s)-3-methylpentanoyl]oxy}pent-3-en-1-yl]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

3-{[(2s,4as,5r,8as)-1,1,4a,6-tetramethyl-5-[(3e)-3-methyl-5-{[(3s)-3-methylpentanoyl]oxy}pent-3-en-1-yl]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C29H46O6 (490.3294)


   

(1r,2r,5s,7r,8r,11r,14r,15r,17r)-5,7-dihydroxy-2-(hydroxymethyl)-15-methyl-14-[(2r)-6-methylheptan-2-yl]-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-9-en-8-yl acetate

(1r,2r,5s,7r,8r,11r,14r,15r,17r)-5,7-dihydroxy-2-(hydroxymethyl)-15-methyl-14-[(2r)-6-methylheptan-2-yl]-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-9-en-8-yl acetate

C29H46O6 (490.3294)


   

13-(acetyloxy)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-hexadecahydrochryseno[1,2-c]furan-4-yl acetate

13-(acetyloxy)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-hexadecahydrochryseno[1,2-c]furan-4-yl acetate

C29H46O6 (490.3294)


   

4,5,16'-trihydroxy-4-isopropyl-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-20'-one

4,5,16'-trihydroxy-4-isopropyl-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-20'-one

C29H46O6 (490.3294)


   

(1s,2s,4as,4br,6ar,8s,9r,10ar,10br)-1,8,9-trihydroxy-7,7-bis(hydroxymethyl)-3',3',4a,4b,10a-pentamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-4'-one

(1s,2s,4as,4br,6ar,8s,9r,10ar,10br)-1,8,9-trihydroxy-7,7-bis(hydroxymethyl)-3',3',4a,4b,10a-pentamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-4'-one

C29H46O6 (490.3294)


   

1-(1,2-dihydroxypropan-2-yl)-6-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-tetradecahydro-1h-cyclopenta[a]chrysene-4,9-dione

1-(1,2-dihydroxypropan-2-yl)-6-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-tetradecahydro-1h-cyclopenta[a]chrysene-4,9-dione

C29H46O6 (490.3294)


   

(1r,6r,7r,9r,10s,12r,15r,16r,18s,20s,21r)-11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

(1r,6r,7r,9r,10s,12r,15r,16r,18s,20s,21r)-11,11-bis(hydroxymethyl)-7,15,16,21-tetramethyl-19-oxahexacyclo[19.2.1.0¹,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]tetracos-3-ene-9,10,20-triol

C29H46O6 (490.3294)


   

2-{3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-6-methylheptan-3-yl acetate

2-{3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-6-methylheptan-3-yl acetate

C29H46O6 (490.3294)